img

Global Autologous Matrix-induced Chondrogenesis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autologous Matrix-induced Chondrogenesis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Autologous matrix-induced chondrogenesis (AMIC) is a surgical technique used to repair cartilage defects in the knee joint.
Autologous Matrix-induced Chondrogenesis report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Autologous Matrix-induced Chondrogenesis market is projected to reach US$ 149.5 million in 2029, increasing from US$ 103.9 million in 2022, with the CAGR of 4.9% during the period of 2024 to 2029. Demand from Knees Joint and Other are the major drivers for the industry.
The market for AMIC is driven by the growing prevalence of knee injuries and osteoarthritis, leading to a demand for advanced and minimally invasive cartilage repair techniques. The increasing focus on sports and physical activities further fuels the adoption of AMIC procedures.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autologous Matrix-induced Chondrogenesis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


JRI Orthopaedics Ltd
BioTissue
Anika Therapeutics
B. Braun Melsungen
Arthro-Kinetics
Geistlich Pharma
CartiHeal
Matricel
Smith & Nephew
Zimmer Biomet Holdings
Segment by Type
Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly Lactic-Co-Glycolic Acid (PGLA)

Segment by Application


Knees Joint
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autologous Matrix-induced Chondrogenesis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Autologous Matrix-induced Chondrogenesis introduction, etc. Autologous Matrix-induced Chondrogenesis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Autologous Matrix-induced Chondrogenesis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Autologous Matrix-induced Chondrogenesis
1.1 Autologous Matrix-induced Chondrogenesis Market Overview
1.1.1 Autologous Matrix-induced Chondrogenesis Product Scope
1.1.2 Autologous Matrix-induced Chondrogenesis Market Status and Outlook
1.2 Global Autologous Matrix-induced Chondrogenesis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autologous Matrix-induced Chondrogenesis Market Size by Region (2018-2029)
1.4 Global Autologous Matrix-induced Chondrogenesis Historic Market Size by Region (2018-2024)
1.5 Global Autologous Matrix-induced Chondrogenesis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
1.6.1 North America Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
1.6.2 Europe Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
1.6.3 Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
1.6.4 Latin America Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
1.6.5 Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size (2018-2029)
2 Autologous Matrix-induced Chondrogenesis Market by Type
2.1 Introduction
2.1.1 Hyaluronic Acid
2.1.2 Collagen
2.1.3 Polyethylene Glycol (PEG)
2.1.4 Poly Lactic-Co-Glycolic Acid (PGLA)
2.2 Global Autologous Matrix-induced Chondrogenesis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autologous Matrix-induced Chondrogenesis Historic Market Size by Type (2018-2024)
2.2.2 Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Type (2018-2029)
3 Autologous Matrix-induced Chondrogenesis Market Overview by Application
3.1 Introduction
3.1.1 Knees Joint
3.1.2 Other
3.2 Global Autologous Matrix-induced Chondrogenesis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Autologous Matrix-induced Chondrogenesis Historic Market Size by Application (2018-2024)
3.2.2 Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Breakdown by Application (2018-2029)
4 Autologous Matrix-induced Chondrogenesis Competition Analysis by Players
4.1 Global Autologous Matrix-induced Chondrogenesis Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autologous Matrix-induced Chondrogenesis as of 2022)
4.3 Date of Key Players Enter into Autologous Matrix-induced Chondrogenesis Market
4.4 Global Top Players Autologous Matrix-induced Chondrogenesis Headquarters and Area Served
4.5 Key Players Autologous Matrix-induced Chondrogenesis Product Solution and Service
4.6 Competitive Status
4.6.1 Autologous Matrix-induced Chondrogenesis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 JRI Orthopaedics Ltd
5.1.1 JRI Orthopaedics Ltd Profile
5.1.2 JRI Orthopaedics Ltd Main Business
5.1.3 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.1.4 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.1.5 JRI Orthopaedics Ltd Recent Developments
5.2 BioTissue
5.2.1 BioTissue Profile
5.2.2 BioTissue Main Business
5.2.3 BioTissue Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.2.4 BioTissue Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.2.5 BioTissue Recent Developments
5.3 Anika Therapeutics
5.3.1 Anika Therapeutics Profile
5.3.2 Anika Therapeutics Main Business
5.3.3 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.3.4 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.3.5 B. Braun Melsungen Recent Developments
5.4 B. Braun Melsungen
5.4.1 B. Braun Melsungen Profile
5.4.2 B. Braun Melsungen Main Business
5.4.3 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.4.4 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.4.5 B. Braun Melsungen Recent Developments
5.5 Arthro-Kinetics
5.5.1 Arthro-Kinetics Profile
5.5.2 Arthro-Kinetics Main Business
5.5.3 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.5.4 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.5.5 Arthro-Kinetics Recent Developments
5.6 Geistlich Pharma
5.6.1 Geistlich Pharma Profile
5.6.2 Geistlich Pharma Main Business
5.6.3 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.6.4 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.6.5 Geistlich Pharma Recent Developments
5.7 CartiHeal
5.7.1 CartiHeal Profile
5.7.2 CartiHeal Main Business
5.7.3 CartiHeal Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.7.4 CartiHeal Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.7.5 CartiHeal Recent Developments
5.8 Matricel
5.8.1 Matricel Profile
5.8.2 Matricel Main Business
5.8.3 Matricel Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.8.4 Matricel Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.8.5 Matricel Recent Developments
5.9 Smith & Nephew
5.9.1 Smith & Nephew Profile
5.9.2 Smith & Nephew Main Business
5.9.3 Smith & Nephew Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.9.4 Smith & Nephew Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.9.5 Smith & Nephew Recent Developments
5.10 Zimmer Biomet Holdings
5.10.1 Zimmer Biomet Holdings Profile
5.10.2 Zimmer Biomet Holdings Main Business
5.10.3 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
5.10.4 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) & (2018-2024)
5.10.5 Zimmer Biomet Holdings Recent Developments
6 North America
6.1 North America Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autologous Matrix-induced Chondrogenesis Market Dynamics
11.1 Autologous Matrix-induced Chondrogenesis Industry Trends
11.2 Autologous Matrix-induced Chondrogenesis Market Drivers
11.3 Autologous Matrix-induced Chondrogenesis Market Challenges
11.4 Autologous Matrix-induced Chondrogenesis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Autologous Matrix-induced Chondrogenesis Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Autologous Matrix-induced Chondrogenesis Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Autologous Matrix-induced Chondrogenesis Market Size Share by Region (2018-2024)
Table 4. Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Autologous Matrix-induced Chondrogenesis Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Autologous Matrix-induced Chondrogenesis Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2024)
Table 9. Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2024-2029)
Table 11. North America Autologous Matrix-induced Chondrogenesis Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Autologous Matrix-induced Chondrogenesis Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Autologous Matrix-induced Chondrogenesis Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Autologous Matrix-induced Chondrogenesis Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Autologous Matrix-induced Chondrogenesis Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Autologous Matrix-induced Chondrogenesis Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Autologous Matrix-induced Chondrogenesis Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Autologous Matrix-induced Chondrogenesis Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2024)
Table 24. Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2024-2029)
Table 26. North America Autologous Matrix-induced Chondrogenesis Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Autologous Matrix-induced Chondrogenesis Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Autologous Matrix-induced Chondrogenesis Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Autologous Matrix-induced Chondrogenesis Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Autologous Matrix-induced Chondrogenesis Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Autologous Matrix-induced Chondrogenesis Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Autologous Matrix-induced Chondrogenesis Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Autologous Matrix-induced Chondrogenesis Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autologous Matrix-induced Chondrogenesis as of 2022)
Table 39. Date of Key Players Enter into Autologous Matrix-induced Chondrogenesis Market
Table 40. Global Autologous Matrix-induced Chondrogenesis Key Players Headquarters and Area Served
Table 41. Autologous Matrix-induced Chondrogenesis Product Solution and Service
Table 42. Global Autologous Matrix-induced Chondrogenesis Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. JRI Orthopaedics Ltd Basic Information List
Table 45. JRI Orthopaedics Ltd Description and Business Overview
Table 46. JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 47. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of JRI Orthopaedics Ltd (2018-2024)
Table 48. JRI Orthopaedics Ltd Recent Developments
Table 49. BioTissue Basic Information List
Table 50. BioTissue Description and Business Overview
Table 51. BioTissue Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 52. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of BioTissue (2018-2024)
Table 53. BioTissue Recent Developments
Table 54. Anika Therapeutics Basic Information List
Table 55. Anika Therapeutics Description and Business Overview
Table 56. Anika Therapeutics Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 57. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Anika Therapeutics (2018-2024)
Table 58. Anika Therapeutics Recent Developments
Table 59. B. Braun Melsungen Basic Information List
Table 60. B. Braun Melsungen Description and Business Overview
Table 61. B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 62. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of B. Braun Melsungen (2018-2024)
Table 63. B. Braun Melsungen Recent Developments
Table 64. Arthro-Kinetics Basic Information List
Table 65. Arthro-Kinetics Description and Business Overview
Table 66. Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 67. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Arthro-Kinetics (2018-2024)
Table 68. Arthro-Kinetics Recent Developments
Table 69. Geistlich Pharma Basic Information List
Table 70. Geistlich Pharma Description and Business Overview
Table 71. Geistlich Pharma Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 72. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Geistlich Pharma (2018-2024)
Table 73. Geistlich Pharma Recent Developments
Table 74. CartiHeal Basic Information List
Table 75. CartiHeal Description and Business Overview
Table 76. CartiHeal Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 77. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of CartiHeal (2018-2024)
Table 78. CartiHeal Recent Developments
Table 79. Matricel Basic Information List
Table 80. Matricel Description and Business Overview
Table 81. Matricel Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 82. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Matricel (2018-2024)
Table 83. Matricel Recent Developments
Table 84. Smith & Nephew Basic Information List
Table 85. Smith & Nephew Description and Business Overview
Table 86. Smith & Nephew Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 87. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Smith & Nephew (2018-2024)
Table 88. Smith & Nephew Recent Developments
Table 89. Zimmer Biomet Holdings Basic Information List
Table 90. Zimmer Biomet Holdings Description and Business Overview
Table 91. Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Products, Services and Solutions
Table 92. Revenue (US$ Million) in Autologous Matrix-induced Chondrogenesis Business of Zimmer Biomet Holdings (2018-2024)
Table 93. Zimmer Biomet Holdings Recent Developments
Table 94. North America Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America Autologous Matrix-induced Chondrogenesis Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe Autologous Matrix-induced Chondrogenesis Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Share by Region (2018-2024)
Table 102. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Share by Region (2024-2029)
Table 103. Latin America Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America Autologous Matrix-induced Chondrogenesis Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size by Country (2024-2029) & (US$ Million)
Table 109. Autologous Matrix-induced Chondrogenesis Market Trends
Table 110. Autologous Matrix-induced Chondrogenesis Market Drivers
Table 111. Autologous Matrix-induced Chondrogenesis Market Challenges
Table 112. Autologous Matrix-induced Chondrogenesis Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Matrix-induced Chondrogenesis Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Autologous Matrix-induced Chondrogenesis Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Autologous Matrix-induced Chondrogenesis Market Share by Regions: 2022 VS 2029
Figure 4. Global Autologous Matrix-induced Chondrogenesis Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Hyaluronic Acid
Figure 11. Global Hyaluronic Acid Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Collagen
Figure 13. Global Collagen Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Polyethylene Glycol (PEG)
Figure 15. Global Polyethylene Glycol (PEG) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Poly Lactic-Co-Glycolic Acid (PGLA)
Figure 17. Global Poly Lactic-Co-Glycolic Acid (PGLA) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Autologous Matrix-induced Chondrogenesis Market Size Share by Type: 2022 & 2029
Figure 19. North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2029)
Figure 20. Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Type (2018-2029)
Figure 24. Knees Joint Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Global Autologous Matrix-induced Chondrogenesis Market Size Share by Application: 2022 & 2029
Figure 27. North America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2029)
Figure 28. Europe Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2029)
Figure 29. Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2029)
Figure 30. Latin America Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2029)
Figure 31. Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue Market Share by Application (2018-2029)
Figure 32. Autologous Matrix-induced Chondrogenesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Autologous Matrix-induced Chondrogenesis Market Share in 2022
Figure 34. North America Autologous Matrix-induced Chondrogenesis Market Share by Country (2018-2029)
Figure 35. U.S. Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 36. Canada Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 37. Germany Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 38. France Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 39. U.K. Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 40. Italy Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 41. Russia Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 42. Nordic Countries Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 43. Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Share by Region (2018-2029)
Figure 44. China Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 45. Japan Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 46. South Korea Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 48. India Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 49. Australia Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 50. Latin America Autologous Matrix-induced Chondrogenesis Market Share by Country (2018-2029)
Figure 51. Mexico Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 52. Brazil Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Autologous Matrix-induced Chondrogenesis Market Share by Country (2018-2029)
Figure 54. Turkey Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 56. UAE Autologous Matrix-induced Chondrogenesis Market Size (2018-2029) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries